FEMY
FEMASYS INC
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$1.40
+0.00%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$1.43
From 52W high−93.27%
Volume72244.00
Market cap$11.73M
P/E (TTM)—
P/S (TTM)5.1x
Div yield—
Key dataNov 4, 2026
Open
$1.43
From 52W high
−93.27%
Volume
72244.00
Market cap
$11.73M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.6x
P/E (TTM)
—
RSI (14)
33.8
MomentumView details →
1D Return
+0.00%
YTD Return
−87.63%
SummaryUpdated Jun 1, 2026
Femasys Inc. (NASDAQ:FEMY) is a biomedical company founded in 2004 and headquartered in Suwanee, Georgia, that specializes in developing and commercializing medical devices for women's healthcare. The company went public in June 2021 and focuses on creating innovative solutions for reproductive health, including permanent birth control, fertility treatments, and diagnostic procedures. Femasys operates in the medical devices sector, specifically targeting the underserved women's healthcare market with proprietary technologies designed to provide minimally invasive alternatives to traditional surgical procedures.
Similar companies
Latest newsMore news →
Femasys said Kenneth D. Eichenbaum resigned as a director and John Moorhead was appointed as a director, effective October 30, 2026.2d agoFEMASYS INC partnered with SandsRx Pharmacy to support the launch of its FemaSeed fertility portfolio to OB/GYNs, providing medication coordination and preferred pricing for physicians and patients.15d ago